Clinical Features and Diagnosis of Frontotemporal Dementia

Frontiers of Neurology and Neuroscience

Volumn 24, Issue , 2009, Pages 140-148

  Kertesz, Andrew ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GALANTAMINE; NEUROLEPTIC AGENT; PROGRANULIN; SEROTONIN UPTAKE INHIBITOR; SYNUCLEIN; TAR DNA BINDING PROTEIN; TRAZODONE; UBIQUITIN;

AMNESIA; AMYOTROPHIC LATERAL SCLEROSIS; ANOMIA; APATHY; APHASIA; APRAXIA; ATAXIC APHASIA; ATTENTION DISTURBANCE; AUTOPSY; BEHAVIOR DISORDER; BRADYKINESIA; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 9; CHROMOSOME MUTATION; COGNITIVE DEFECT; COMPULSIVE PERSONALITY DISORDER; CORTICOBASAL DEGENERATION; DEPRESSION; DISORIENTATION; DISTRACTIBILITY; DYSPHAGIA; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FALLING; FRONTOTEMPORAL DEMENTIA; GAZE PARALYSIS; HIPPOCAMPAL SCLEROSIS; HUMAN; HYPERSEXUALITY; IMPULSIVENESS; INCIDENCE; KLUVER BUCY SYNDROME; MANIC PSYCHOSIS; MOTOR NEURON DISEASE; MYOCLONUS; NEUROIMAGING; PERSONALITY DISORDER; PREDICTION; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DEFECT; PSYCHOPATHY; REVIEW; RIGIDITY; SEMANTIC DEMENTIA; CLASSIFICATION; DEMENTIA; PATHOPHYSIOLOGY;

DEMENTIA; HUMANS;

EID: 65349085725     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000197893     Document Type: Review

References (34)

1. Pick A: Über die Beziehungen der senilen Hirnatrophie zur Aphasie. Prag Med Wochenschr 1892;17:165-167.
2. Gustafson L: Frontal lobe degeneration of non-Alzheimer type II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987;6:209-223.
3. The Lund and Manchester Groups: Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57: 416-418.
4. Mesulam M-M: Primary progressive aphasia - differentiation from Alzheimer's disease. Ann Neurol 1987;22:533-534.
5. Kertesz A, Hudson L, Mackenzie IRA, et al: The pathology and nosology of primary progressive aphasia. Neurology 1994;44:2065-2072.
6. Neary D, Snowden JS, Gustafson L, et al: Frontotemporal lobar degeneration - a consensus on clinical diagnostic criteria. Neurology 1998;51: 1546-1554.
7. Gregory CA, Hodges JR: Frontotemporal dementia: use of consensus criteria and prevalence of psychiatric features. Neuropsychiatry Neuropsychol Behav Neurol 1996;9:145-153.
8. Cummings JL, Duchen LW: Kluver-Bucy syndrome in Pick disease: clinical and pathologic correlations. Neurology 1981;31:1415-1422.
9. Grossman M, Mickanin J, Onishi C et al: Progressive nonfluent aphasia, language, cognitive and PET measures contrasted with probable Alzheimer's disease. J Cog Neurosci 1996;8:135-154.
10. Cohen L, Benoit N, Van Eeckhout P, Ducarne B, Brunet P: Pure progressive aphemia. J Neurol Neurosurg Psychiatry 1993;56:923-924.
11. Weintraub S, Rubin NP, Mesulam M-M: Primary progressive aphasia: longitudinal course, neuropsychological profile, and language features. Arch Neurol 1990;47:1329-1335.
12. Snowden JS, Goulding PJ, Neary D: Semantic dementia: a form of circumscribed cerebral atrophy. Behav Neurol 1989;2:167-182.
13. Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 1992;115:1783-1806.
14. Rebeiz JJ, Kolodny EH, Richardson EP Jr: Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33.
15. Gibb WRG, Luthert PJ, Marsden CD: Corticobasal degeneration. Brain 1989;112:1171-1192.
16. Lang AE, Bergeron C, Pollanen MS, Ashby P: Parietal Pick's disease mimicking cortical-basal degeneration. Neurology 1992;44:1436-1440.
17. Lippa CF, Smith TW, Fontneau N: Corticonigral degeneration with neuronal achromasia. A clinico-pathological study of two cases. JNS 1990;98: 301-310.
18. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG: The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000;55:1368-1375.
19. Steele JC, Richardson JC, Olszewski J: Progressive supranuclear palsy. Arch Neurol 1964;10:333-359.
20. Josephs KA, Petersen RC, Knopman DS, et al: Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006;66:41-48.
21. Pillon B, Blin J, Vidailhet M, et al: The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995;45: 1477-1483.
22. Lomen-Hoerth C, Anderson T, Miller B: The overlap of amyotrophic lateral sclerosis and frontotem-poral dementia. Neurology 2002;59:1077-1079.
23. Neary D, Snowden JS, Mann DMA, Northen B, Goulding PJ, Macdermott N: Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 1990;53:23-32.
24. Munoz DG, Dickson DW, Bergeron C, Mackenzie IRA, Delacourte A, Zhukareva V: The neuropathology and biochemistry of frontotemporal dementia. Ann Neurol 2003;54(suppl 5):S24-S28.
25. Kertesz A, Davidson W, McCabe P, Munoz D: Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia. Alzheimer Dis Assoc Disord 2003;17:223-229.
26. Miller BL, Cummings JL, Villanueva-Meyer J, et al: Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991;41:1374-1382.
27. Hodges JR, Garrard P, Perry R, et al:. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology 1999;13:31-40.
28. Hutton M, Lendon CL, Rizzu P, et al: Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393: 702-705.
29. Baker M, Mackenzie IR, Pickering-Brown SM: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-919.
30. Kertesz A, Blair M, McMonagle P, Munoz DG: The diagnosis and course of frontotemporal dementia. Alzheimer Dis Assoc Disord 2007;21:155-163.
31. Skibinski G, Parkinson NJ, Brown JM, et al: Mutation in the endosomal ESCRT-III complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005;37:806-808.
32. Watts GD, Wymer J, Kovach MJ, et al: Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004; 36:377-381.
33. Neumann M, Sampathu DM, Kwong LK, et al: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133.
34. Sreedharan J, Blair I P, Tripathi VB et al: TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008;319:1668-1672.